New Delhi: Bharat Biotech has said that it will be advisable to participate in the Phase 3 efficacy trial for its indigenous Covaxin and get vaccinated to ensure protection against Covid-19 as it may take months for people above 50 years to get the vaccine. In frequently asked questions (FAQ) on its vaccine trials, Bharat […]
New Delhi: The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech’s ‘Covaxin’ for emergency use in India. However, the final decision on its approval will be taken by the Drug Controller General of India (DCGI). Expert panel recommends granting permission for restricted emergency use authorization for Bharat Biotech’s indigenously […]
New Delhi: The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC’s recommendation to grant REU approval to Bharat Biotech’s COVAXIN in “clinical trial mode” and “specially in the context of infection by mutant strains”. “In light of the intense concerns arising from the absence of efficacy data and […]
New Delhi: Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution as the immunisation drive in the country is set to start in coming days, its CMD Dr Krishna Ella said on Monday. “We have already sent the batch to the Central Research Institute in […]
New Delhi: Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of COVID-19 vaccines in the country and the world. In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, […]
New Delhi: Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively. However, BBIL will provide 16.5 lakh doses of Covaxin free of cost […]
Bhubaneswar: With the ‘vaccine hesitancy’ getting manifested in nearly half a dozen districts– including the Capital City– in the State despite a mere 0.01 per cent showing any AEFI (adverse events following immunisation) signs, the two vaccine manufacturers – Bharat Biotech and Serum Institute India – have released fact-sheets that tell who are eligible for […]
Hyderabad: Bharat Biotech on Wednesday announced the first interim analysis of Covaxin, which shows the efficacy of the Covid-19 vaccine to be at 81 per cent. The Hyderabad-based vaccine maker said whole virion inactivated Covid-19 vaccine candidate demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved […]
New Delhi: Bharat Biotech’s Covaxin has a negligible number of side effects reported among the beneficiaries of the Covid-19 vaccine, NITI Aayog’s Member (Health), VK Paul said on Thursday. “The vaccine has been administered so far to 19 lakh people and only 311 individuals of them have reported minimal side effects. “It has stood the […]
New Delhi: Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest, and hence, the adverse reactions are lesser. In a series of frequently asked questions (FAQs) for its […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.
LIVE TV
